Clinical Trials

Showing of 1 - 20 from 58 results
Clinical Trials - Total results - 58
India will review claims of AstraZeneca vaccine causing blood clots in 'unusual' sites
India

India will review claims of AstraZeneca vaccine causing blood clots in 'unusual' sites

There have been no reports of cases in India, authorities are still looking into claims as many countries have either stopped or limited the use of the vaccine.

AstraZeneca's Britain COVID-19 vaccine clinical trials for children paused due to blood clot concerns
World

AstraZeneca's Britain COVID-19 vaccine clinical trials for children paused due to blood clot concerns

Britain and the vaccine's developers had until now resisted any restrictions in its use, saying that there was no proof of any link.

Researchers are hatching a new low-cost COVID-19 vaccine in chicken eggs
science

Researchers are hatching a new low-cost COVID-19 vaccine in chicken eggs

If NDV-HXP-S proves safe and effective, flu vaccine manufacturers could potentially produce well over a billion doses of it a year.

Do not use 'miracle cure' ivermectin on COVID-19 patients says WHO
science

Do not use 'miracle cure' ivermectin on COVID-19 patients says WHO

Like anti-malaria drug hydroxychloroquine — so far unproven by clinical trials — ivermectin is widely available and cheap.

Moderna to begin COVID-19 vaccine trials for children under the age of 12
science

Moderna to begin COVID-19 vaccine trials for children under the age of 12

The benefits of vaccinating children are direct like preventing rare serious pediatric Covid-19 and MIS-C but also indirect like limiting spread.

South Africa's COVID-19 vaccine trials saved the world from another long year of surprises
science

South Africa's COVID-19 vaccine trials saved the world from another long year of surprises

the trial in South Africa underscored the need to stamp out the virus before it mutates further.

Bharat Biotech’s intranasal vaccine for COVID-19: Everything we know so far about BBV154
India

Bharat Biotech’s intranasal vaccine for COVID-19: Everything we know so far about BBV154

The intranasal vaccine BBV154 is being tested to check if it prevents infection, halts person-to-person transmission, and progression of COVID-19.

TATA, CSIR in talks with Moderna to conduct trials, bring COVID-19 vaccine to India
India

TATA, CSIR in talks with Moderna to conduct trials, bring COVID-19 vaccine to India

Moderna's vaccine is based on mRNA technology and it 94 percent effective at preventing COVID-19 in people who were given two doses and had no history of the infection.

Johnson and Johnson expects COVID-19 vaccine results soon but lags behind in production
science

Johnson and Johnson expects COVID-19 vaccine results soon but lags behind in production

In 2021, Johnson & Johnson promised to supply 200 million doses to Covax and will supply another 300 million to Covax in 2022.

AIPSN urges govt to reconsider emergency approval for Covaxin till Phase 3 data is published
India

AIPSN urges govt to reconsider emergency approval for Covaxin till Phase 3 data is published

Either pausing or cancelling approvals is not unheard of, and the CDSCO does have the authority to do so.

Chinese COVID-19 vaccine CoronaVac  shows 78 percent efficacy in Phase 3 trials in Brazil
science

Chinese COVID-19 vaccine CoronaVac shows 78 percent efficacy in Phase 3 trials in Brazil

Turkey, which also helped carry out CoronaVac's Phase 3 tests, said the vaccine had shown the effectiveness of 91.25 percent in its trials.

Caught in deadly race with new COVID strain, Britain 'gambles' with mix-and-match vaccine regimen
World

Caught in deadly race with new COVID strain, Britain 'gambles' with mix-and-match vaccine regimen

Scientists have slammed the new guidance which allows for the interchange of vaccines, if the second dose of the vaccine originally received is not available, saying officials have abandoned science and are just trying to 'guess their way out of a mess'

As more COVID-19 vaccines get approval, experts debate if it's time for trial volunteers to get the real thing
India

As more COVID-19 vaccines get approval, experts debate if it's time for trial volunteers to get the real thing

In an ideal world, vaccine trial participants could hold off to discover whether they received the dummy shot or the vaccine. But experts agree the current circumstances are extraordinary

Oral antiviral drug Molnupiravir can block spread of SARS-CoV-2 virus in ferrets, study shows
science

Oral antiviral drug Molnupiravir can block spread of SARS-CoV-2 virus in ferrets, study shows

Molnupiravir is now in the advanced phase, multi-centre, clinical II/III trials in human beings after successful completion of phase I safety trials.

India doesn't need Pfizer COVID-19 shot; vaccine should be available by Feb-March: Harsh Vardhan
India

India doesn't need Pfizer COVID-19 shot; vaccine should be available by Feb-March: Harsh Vardhan

The health minster said that no state will be given preferential treatment and the distribution of vaccines will be equitable.

Oxford vaccine candidate found safe in elderly, offered immunity against SARS-CoV-2 in all age groups
science

Oxford vaccine candidate found safe in elderly, offered immunity against SARS-CoV-2 in all age groups

Two weeks after volunteers were administered a second dose, over 99 percent of them had neutralising antibody responses regardless of age.

What are monoclonal antibodies ? Why do we need them as well as a COVID-19 vaccine?
science

What are monoclonal antibodies ? Why do we need them as well as a COVID-19 vaccine?

The FDA issued emergency use authorization for Eli Lilly’s monoclonal antibody while Regeneron is still awaiting the FDA’s green light for its antibody treatment.

Volunteers to be exposed to COVID-19 virus to find the amount of virus it take to infect a person
science

Volunteers to be exposed to COVID-19 virus to find the amount of virus it take to infect a person

The volunteer would be infected via the nose and the results will be used to study how vaccines might work and to explore potential treatments.

DCGI approves Dr Reddy's request to conduct Phase 2, 3 clinical trials with Russia's Sputnik V COVD-19 vaccine
science

DCGI approves Dr Reddy's request to conduct Phase 2, 3 clinical trials with Russia's Sputnik V COVD-19 vaccine

RDIF will also supply 100 million doses of Dr Reddy's after receiving Indian regulatory approval.

Why even vital medicines, vaccines are rarely tested for safety in pregnant women
science

Why even vital medicines, vaccines are rarely tested for safety in pregnant women

For decades, expecting mothers have been considered a vulnerable group, for the potential harm to their fetuses’ health.